Rapid Progression of Low-Grade Cervical Dysplasia into Invasive Cancer during Natalizumab Treatment for Relapsing Remitting Multiple Sclerosis
A 25-year-old patient treated for relapsing remitting multiple sclerosis (RRMS) with natalizumab had a rapid progression of a low grade squamous intraepithelial lesion to a FIGO stage 1B1 squamous cell carcinoma of the uterine cervix within 2 years. She was treated with radical hysterectomy and pelv...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Karger Publishers
2019-01-01
|
| Col·lecció: | Case Reports in Oncology |
| Matèries: | |
| Accés en línia: | https://www.karger.com/Article/FullText/496198 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|